🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
Massey Cancer Center
Start Date
1995-02
Trial ID
NCT00002818
Treatments Being Tested
Carboplatin, nab-paclitaxel, and nivolumab combination will be administered...
Status
Completed
Location
University of Chicago Medical Center
Start Date
2017-06-27
Trial ID
NCT03107182
A phase I trial to determine the safety of delivering three sequentially sh...
Status
Active Not Recruiting
Location
Maryland Proton Treatment Center
Start Date
2020-11-19
Trial ID
NCT04486755
Treatments Being Tested
This is a multicenter, randomized, phase III non-inferiority trial in women...
Status
Not Yet Recruiting
Location
Samsung Medical Center
Start Date
2026-08-01
Trial ID
NCT07757958
Treatments Being Tested
PRO-BOOST-N is a prospective, multicenter, randomized phase II/III clinical...
Status
Recruiting
Location
Affidea Nu-Med, Center of Oncological Diagnostics and Therapy
Start Date
2026-03-19
Trial ID
NCT07426094
The aim of this clinical trial is to evaluate the efficacy of adaptive pros...
Status
Recruiting
Location
Centre Eugène Marquis
Start Date
2026-03-02
Trial ID
NCT07189598
This is a multicenter, randomized, open-label, non-inferiority clinical tri...
Status
Not Yet Recruiting
Location
Shanghai Ninth Peolple's Hospital
Start Date
2026-01-01
Trial ID
NCT07320690
Treatments Being Tested
RATIONALE: A donor peripheral stem cell transplant helps stop the growth of...
Status
Terminated
Location
Masonic Cancer Center, University of Minnesota
Start Date
2008-06
Trial ID
NCT00725062
Treatments Being Tested
The goal of this clinical trial is to learn if adding metastasis-directed r...
Status
Not Yet Recruiting
Location
AZorg Aalst
Start Date
2026-11
Trial ID
NCT07782112
Treatments Being Tested
This is a Phase 1, multicenter, open-label dose escalation study to determi...
Status
Recruiting
Location
National Cancer Institute
Start Date
2024-01-19
Trial ID
NCT06171750
Treatments Being Tested